首页> 外国专利> Chimeric Antigen receptor (CAR) comprising an Antigen binding domain, which binds selectively to the constant region of the TCR beta 1 (trbc1) or T Cell trbc2

Chimeric Antigen receptor (CAR) comprising an Antigen binding domain, which binds selectively to the constant region of the TCR beta 1 (trbc1) or T Cell trbc2

机译:包含抗原结合结构域的嵌合抗原受体(CAR),该结构域选择性地与TCR beta 1(trbc1)或T细胞trbc2的恒定区结合

摘要

Refers to a Chimeric receptor (CAR) comprising an Antigen binding domain, which binds selectively to the constant region of the TCR beta 1 (trbc1 trbc2) or T Cell; the car that binds to trbc1 where the Antigen binding domain has a variable heavy chain (VH) that Comprises of SEQ ID no: CDR1, CDR2 7, SEQ ID no: 8CDr3 of SEQ ID no: 9 and a string variable Light (VL) which includes: CDR1 of SEQ ID no: 1, SEQ ID no: 11 of CDR2 and CDr3 of SEQ ID no: 12. It also refers to a method. The Invention is useful in the treatment of lymphoma or Leukemia T Cells
机译:指包含抗原结合结构域的嵌合受体(CAR),该结构域选择性地与TCR beta 1(trbc1 trbc2)或T细胞的恒定区结合。与trbc1结合的汽车,其中抗原结合结构域具有可变重链(VH),该可变重链由SEQ ID no:CDR1,CDR2 7,SEQ ID no:8CDr3,SEQ ID no:9和字符串可变Light(VL)组成其包括:SEQ ID No:1的CDR1,CDR2的SEQ ID No:11和SEQ ID No:12的CDr3。本发明可用于治疗淋巴瘤或白血病T细胞

著录项

  • 公开/公告号PE01252017A1

    专利类型

  • 公开/公告日2017-03-16

    原文格式PDF

  • 申请/专利权人 UCL BUSINESS PLC;

    申请/专利号PE20160001548

  • 发明设计人 PULE MARTIN;MACIOCIA PAUL;

    申请日2015-03-05

  • 分类号A61K39/395;C07K14/725;C07K16/28;

  • 国家 PE

  • 入库时间 2022-08-21 13:37:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号